You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

autologous hematopoetic stem cell transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

Recruiting
  • Relapsing Multiple Sclerosis
  • +2 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • Best Available Therapy (BAT)
  • Palo Alto, California
  • +20 more
Jan 25, 2023

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

Premature Ovarian Failure Trial in Ulaanbaatar (stem cell therapy)

Not yet recruiting
  • Premature Ovarian Failure
  • stem cell therapy
  • Ulaanbaatar, Mongolia
    Mongolian National University of Medical Science
Nov 13, 2023

Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

Active, not recruiting
  • Plasma Cell Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 21, 2022

Aging Problems, Aging, Chronic Inflammation Trial in Ho Chi Minh City (autologous adipose-derived mesenchymal stem cell

Completed
  • Aging Problems
  • +2 more
  • autologous adipose-derived mesenchymal stem cell transplantation
  • Ho Chi Minh City, District 05, Vietnam
    DNA International Hospital
Apr 23, 2023

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,

Terminated
  • Relapsing-Remitting Multiple Sclerosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Hamburg, Germany
  • +1 more
Mar 1, 2022

B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)

Recruiting
  • B-cell Lymphoma
  • ASCT+CAR-T Cell Infusion
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Multiple Sclerosis Trial (hematopoetic stem cell infusion)

Active, not recruiting
  • Multiple Sclerosis
  • hematopoetic stem cell infusion
  • (no location specified)
Jul 15, 2022

Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)

Recruiting
  • Well-being of Caregivers (Caregiver Strain Index)
  • home care
  • Durham, North Carolina
    Duke University Medical Center
Jan 25, 2023

Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

Active, not recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Spinal Cord Injuries Trial in Salvador (Mesenchymal stem cell transplantation, Placebo)

Not yet recruiting
  • Spinal Cord Injuries
  • Mesenchymal stem cell transplantation
  • Placebo
  • Salvador, Bahia, Brazil
    Senai Cimatec
Jan 10, 2023

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

    Not yet recruiting
    • Multiple Myeloma
    • Stem Cell Transplant Complications
    • PARE
    • Waitlist Control Group
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 30, 2023

    ASCT Versus Chemotherapy as First-Line Consolidation Therapy

    Completed
    • T-cell Lymphoma Adults
    • consolidation with ASCT
    • (no location specified)
    Nov 25, 2023

    Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

    Recruiting
    • Multiple Myeloma
    • Autologous hematopoietic stem cell transplantation
    • C-CAR088
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 21, 2022

    Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

    Recruiting
    • Multiple Myeloma
    • Total Marrow irradiation，TMI
    • Autologous hematopoietic stem cell transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 24, 2023

    Metachromatic Leukodystrophy Trial in Durham (Enriched Hematopoetic Stem Cell Infusion)

    No longer available
    • Metachromatic Leukodystrophy
    • Enriched Hematopoetic Stem Cell Infusion
    • Durham, North Carolina
      Duke University
    Jul 15, 2022

    Knee Osteoarthritis Trial in Yantai (Auotologous BMSCs plus autologous PRP, Auotologous PRP)

    Recruiting
    • Knee Osteoarthritis
    • Auotologous BMSCs plus autologous PRP
    • Auotologous PRP
    • Yantai, Shandong, China
      Yantai Yuhuangding Hospital
    Aug 2, 2022

    Muscle Stem Cell Quality in Atrophy

    Not yet recruiting
    • Muscle Weakness
    • +5 more
    • In vitro analyse
    • (no location specified)
    Oct 5, 2023

    Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
    • (no location specified)
    Oct 30, 2023

    Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation

    Active, not recruiting
    • Scleroderma
    • +2 more
    • Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
    • Tuebingen, Germany
      University Hospital Tuebingen; Department of oncology, hematolog
    May 16, 2022

    Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Stem cell infusion
    • +5 more
    • Saint Louis, Missouri
      Washington University
    Jan 17, 2023